Evidence map›Paper›PMID 26399890›Full record

ArticleIntensive care medicine2015

Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: yes.

Claude Guérin, Jordi Mancebo

Registry-linked trialAbstract readEditorial
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03376854 (Pilot Randomized Clinical Trial of Therapeutic Hypothermia Plus Neuromuscular Blockade vs. Standard of Care in COVID-19 Patients With Moderate to Severe ARDS - the Cooling to Help Injured Lungs), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03376854 phase2withdrawnnot on this mapstarted 2018, after this paper: background citation

Pilot Randomized Clinical Trial of Therapeutic Hypothermia Plus Neuromuscular Blockade vs. Standard of Care in COVID-19 Patients With Moderate to Severe ARDS - the Cooling to Help Injured Lungs (CHILL) Pilot Study

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2018 to 2021Enrolled0ConditionsRespiratory Distress Syndrome, Adult, Sars-CoV2ArmsHypothermia, Neuromuscular Blocking Agents, Standard of Care
3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Review
  8. Review
  9. Myorelaxants in ARDS patients.Intensive care medicine · 2020
    Review
  10. Article
  11. Review
  12. Corticosteroids in Acute Lung Injury: The Dilemma Continues.International journal of molecular sciences · 2019
    Review
  13. Review
  14. Article
  15. Article
  16. Current Concepts of ARDS: A Narrative Review.International journal of molecular sciences · 2016
    Review
  17. Article
  18. Severe hypoxemia: which strategy to choose.Critical care (London, England) · 2016
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claude GuérinRéanimation Médicale, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Université de Lyon, Lyon, France.
Jordi ManceboServei de Medicina Intensiva, Hospital de Sant Pau, C. St Quintí 89, 08041, Barcelona, Spain. jmancebo@santpau.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Positive-Pressure Respiration, IntrinsicProne PositionCombined Modality TherapyHumansNeuromuscular Blocking AgentsRespiratory Distress SyndromeSeverity of Illness IndexNeuromuscular Blocking Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.